EyePoint Pharmaceuticals' lead product, EYP-1901, shows promising phase 2 results for wet AMD and DME. Read more about EYPT ...

Novartis and Roche's big-selling eye drug Lucentis has its first biosimilar ... be used to treat proliferative diabetic retinopathy (PDR), macular oedema caused by retinal vein occlusion (RVO ...

The new rules, which cover both TV and radio, instruct drugmakers to use simple, consumer-friendly language when describing ...

Sierra Space has passed the preliminary design review (PDR) for 18 satellites it is building for the Space Development Agency’s (SDA) future proliferated satellite constellation in low Earth ...

Revuforj is the first so-called menin inhibitor cleared in the U.S., securing FDA approval for use in adults and certain ...

The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...

In a recent presentation at the 25th Annual Pharmaceutical and Medical Device Ethics and Compliance Congress, Catherine Gray, ...

A key deadline for the incoming administration is Feb. 1, 2025, by which Medicare must select up to 15 high-cost drugs to negotiate prices on. While the Biden administration may select these drugs ...

Lindsay Bealor Greenleaf, JD, MBA, of ADVI Health, weighs in on what to expect in key health care policy areas in the wake of ...

The FDA has implemented new rules for TV and radio drug ads, effective Nov. 20, aimed at making the advertisements more clear and direct in explaining medication risks and side effects, The Sun ...